Instil Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Instil Bio
TIL Stock  USD 21.63  1.75  8.80%   
Instil Bio financial statements provide useful quarterly and yearly information to potential Instil Bio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Instil Bio financial statements helps investors assess Instil Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Instil Bio's valuation are summarized below:
Gross Profit
138 K
Market Capitalization
129.7 M
Enterprise Value Revenue
43.2 K
Earnings Share
(11.39)
There are over one hundred nineteen available fundamental trends for Instil Bio, which can be analyzed over time and compared to other ratios. We recommend to confirm Instil Bio's regular fundamental drivers against the all of the trends between 2010 and 2025. The value of Market Cap is estimated to slide to about 118.1 M. The Enterprise Value is projected to slide to about 110.7 M
Check Instil Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Instil Bio's main balance sheet or income statement drivers, such as Interest Income of 3.5 M, Depreciation And Amortization of 3.2 M or Interest Expense of 8.4 M, as well as many indicators such as Price To Sales Ratio of 19.7 K, Dividend Yield of 0.0 or PTB Ratio of 0.77. Instil financial statements analysis is a perfect complement when working with Instil Bio Valuation or Volatility modules.
  
Check out the analysis of Instil Bio Correlation against competitors.
For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.

Instil Bio Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets368.5 M263.6 M154 M
Slightly volatile
Other Current Liabilities6.9 M7.2 M6.2 M
Slightly volatile
Total Current Liabilities7.5 M7.9 M8 M
Slightly volatile
Property Plant And Equipment Net120.7 M130.3 M48.8 M
Slightly volatile
Accounts Payable626 K659 K1.5 M
Pretty Stable
Cash8.4 M8.8 M27.4 M
Pretty Stable
Non Current Assets Total134.9 M139.1 M54.5 M
Slightly volatile
Cash And Short Term Investments225.4 M113.3 M95.9 M
Slightly volatile
Common Stock Shares Outstanding7.1 M6.5 M6.5 M
Slightly volatile
Liabilities And Stockholders Equity368.5 M263.6 M154 M
Slightly volatile
Non Current Liabilities Total84.7 M86.2 M53.4 M
Slightly volatile
Other Current Assets9.4 M11.2 M3.8 M
Slightly volatile
Total Liabilities99 M94.1 M61.8 M
Slightly volatile
Property Plant And Equipment Gross124.5 M135.1 M50.3 M
Slightly volatile
Total Current Assets233.6 M124.5 M99.5 M
Slightly volatile
Net Working Capital213.9 M116.6 M90.7 M
Slightly volatile
Property Plant Equipment147.3 M140.3 M44.4 M
Slightly volatile
Other Liabilities14.7 M15.4 M13.6 M
Slightly volatile
Non Currrent Assets Other5 M8.8 M2.8 M
Slightly volatile
Other Assets1 M1.1 M48.7 M
Pretty Stable
Net Receivables6.2 M9.4 M4.7 M
Slightly volatile
Inventory944.8 K1.1 M1.2 M
Slightly volatile
Deferred Long Term Liabilities1.3 M1.5 M1.6 M
Slightly volatile
Non Current Liabilities Other979.5 K1 M9.1 M
Slightly volatile
Intangible Assets8.1 M9.1 M9.9 M
Slightly volatile
Capital Surpluse605.6 M681.3 M742.8 M
Slightly volatile
Short and Long Term Debt Total966.1 K1 M70.4 M
Slightly volatile
Long Term Debt87.3 M84.2 M74.6 M
Slightly volatile
Short Term Debt1.7 M1.6 M2.2 M
Slightly volatile

Instil Bio Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income3.5 M7 M1.5 M
Slightly volatile
Depreciation And Amortization3.2 M3.6 M1.3 M
Slightly volatile
Selling General Administrative40.2 M44.2 M17.7 M
Slightly volatile
Other Operating Expenses103.3 M73.5 M45.4 M
Slightly volatile
Research Development9.5 M10 M23.2 M
Slightly volatile
Cost Of Revenue3.7 M5.5 M1.6 M
Slightly volatile
Total Operating Expenses102.4 M73.5 M45 M
Slightly volatile
Reconciled Depreciation3.4 M3.6 M1.4 M
Slightly volatile
Selling And Marketing Expenses3.8 M4.3 M4.7 M
Slightly volatile

Instil Bio Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation17.2 M17.3 M7.1 M
Slightly volatile
Depreciation3.2 M3.6 M1.3 M
Slightly volatile
Other Non Cash Items17 M10.2 M7.2 M
Slightly volatile
Capital Expenditures9.5 M10 M15.1 M
Slightly volatile
Change To Operating Activities1.1 M573.9 K393.8 K
Slightly volatile
Total Cash From Financing Activities1.7 M1.8 M58.7 M
Pretty Stable
End Period Cash Flow10.1 M10.6 M27.7 M
Pretty Stable
Change To Netincome33.3 M31.7 M10.1 M
Slightly volatile
Sale Purchase Of Stock314.6 M353.9 M385.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio19.7 K22.1 K24.1 K
Slightly volatile
Days Sales Outstanding6.7 K7.6 K8.2 K
Slightly volatile
Stock Based Compensation To Revenue9.8911.1312.1308
Slightly volatile
Capex To Depreciation4.755.0140
Slightly volatile
EV To Sales18.3 K20.5 K22.4 K
Slightly volatile
Payables Turnover3.713.530.9309
Slightly volatile
Sales General And Administrative To Revenue83.3893.8102
Slightly volatile
Research And Ddevelopement To Revenue112127138
Slightly volatile
Capex To Revenue295331361
Slightly volatile
Cash Per Share25.3817.405914.2603
Slightly volatile
Days Payables Outstanding10210711.3 K
Slightly volatile
Income Quality0.810.75130.7858
Slightly volatile
Intangibles To Total Assets0.04160.02980.0434
Slightly volatile
Current Ratio10.0615.76379.0257
Slightly volatile
Receivables Turnover0.03480.03910.0427
Slightly volatile
Debt To Equity0.00570.0060.2031
Slightly volatile
Capex Per Share5.322.862.656
Slightly volatile
Revenue Per Share0.01720.01940.0211
Slightly volatile
Interest Debt Per Share1.321.384611.3076
Slightly volatile
Debt To Assets0.00370.00390.1516
Slightly volatile
Operating Cycle6.7 K7.6 K8.2 K
Slightly volatile
Days Of Payables Outstanding10210711.3 K
Slightly volatile
Ebt Per Ebit0.911.00811.0416
Slightly volatile
Long Term Debt To Capitalization0.00570.0060.1521
Slightly volatile
Total Debt To Capitalization0.00570.0060.1644
Slightly volatile
Debt Equity Ratio0.00570.0060.2031
Slightly volatile
Quick Ratio10.0615.76379.0201
Slightly volatile
Net Income Per E B T1.11.141.0076
Slightly volatile
Cash Ratio1.061.11515.3831
Slightly volatile
Days Of Sales Outstanding6.7 K7.6 K8.2 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.771.441.3473
Slightly volatile
Fixed Asset Turnover0.0020.00220.0024
Slightly volatile
Debt Ratio0.00370.00390.1516
Slightly volatile
Price Sales Ratio19.7 K22.1 K24.1 K
Slightly volatile
Asset Turnover3.0E-44.0E-44.0E-4
Slightly volatile

Instil Bio Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap118.1 M124.3 M2.5 B
Slightly volatile
Enterprise Value110.7 M116.5 M2.5 B
Slightly volatile

Instil Fundamental Market Drivers

Cash And Short Term Investments113.3 M

Instil Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Instil Bio Financial Statements

Instil Bio investors utilize fundamental indicators, such as revenue or net income, to predict how Instil Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Cost Of Revenue5.5 M3.7 M
Stock Based Compensation To Revenue 11.13  9.89 
Sales General And Administrative To Revenue 93.80  83.38 
Research And Ddevelopement To Revenue 126.52  112.46 
Capex To Revenue 331.41  294.58 
Revenue Per Share 0.02  0.02 
Ebit Per Revenue(219.42)(230.39)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Instil Bio is a strong investment it is important to analyze Instil Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instil Bio's future performance. For an informed investment choice regarding Instil Stock, refer to the following important reports:
How To Invest In Instil
Details
Is Instil Stock a good investment?
Details
What is Instil Bio's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Instil Bio Correlation against competitors.
For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instil Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.39)
Return On Assets
(0.13)
Return On Equity
(0.38)
The market value of Instil Bio is measured differently than its book value, which is the value of Instil that is recorded on the company's balance sheet. Investors also form their own opinion of Instil Bio's value that differs from its market value or its book value, called intrinsic value, which is Instil Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instil Bio's market value can be influenced by many factors that don't directly affect Instil Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY